?:authorAffiliation
|
-
[\'MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, UK; Haematology Theme, Oxford Biomedical Research Centre, Oxford, UK. Electronic address: alexander.drakesmith@imm.ox.ac.uk.\', \'Population Health and Immunity Division, Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia; Diagnostic Haematology, The Royal Melbourne Hospital, Parkville, VIC, Australia; Clinical Haematology, The Peter MacCallum Cancer Centre and The Royal Melbourne Hospital, Parkville, VIC, Australia; Department of Medical Biology, The University of Melbourne, Parkville, VIC, Australia.\', \'Institute of Life Sciences, Hebrew University of Jerusalem, Jerusalem, Israel.\', \'Internal Medicine, Hadassah Medical School, Hebrew University of Jerusalem, Jerusalem, Israel.\', \'Department of Internal Medicine II, Infectious Diseases, Immunology, Rheumatology, Pneumology, Medical University of Innsbruck, Innsbruck, Austria.\', \'Department of Medicine, Section of Internal Medicine, University of Verona, Verona, Italy.\', \'Department of Health Sciences and Technology, ETH Zurich, Zurich, Switzerland.\', \'Department of Pediatric Hematology, Oncology and Immunology, University of Heidelberg, Heidelberg, Germany; Molecular Medicine Partnership Unit, Heidelberg, Germany.\', \'Center for Iron Disorders, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.\', \'Division of Genetics and Cell Biology, San Raffaele Scientific Institute, Milano, Italy.\', \'Peter Medawar Building for Pathogen Research, University of Oxford, Oxford, UK; Oxford NIHR Biomedical Research Centre, John Radcliffe Hospital, Oxford, UK.\', \'MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, UK; Department of Health Sciences and Technology, ETH Zurich, Zurich, Switzerland.\']
|